Anti mouse igg or protein a

Manufactured by GE Healthcare

Anti-mouse IgG or protein-A is a laboratory reagent used for the detection and purification of mouse immunoglobulin G (IgG) proteins. It functions by specifically binding to the Fc region of mouse IgG, allowing for the separation and identification of these antibodies in samples.

Automatically generated - may contain errors

Lab products found in correlation

Horseradish peroxidase, by GE Healthcare (2 mentions) Alexa fluor 488, by Thermo Fisher Scientific (2 mentions) Alexa fluor 594, by Thermo Fisher Scientific (2 mentions) Ha y 11, by Santa Cruz Biotechnology (2 mentions) Anti rabbit igg, by Thermo Fisher Scientific (2 mentions) Anti mouse igg, by Thermo Fisher Scientific (2 mentions) Cul1 2h4c9, by Merck Group (2 mentions) Anti rabbit igg, by GE Healthcare (2 mentions) Flag tag (flag), by Cell Signaling Technology (2 mentions) Flag m2, by Fortrea (2 mentions) β actin, by Fortrea (2 mentions)

2 protocols using anti mouse igg or protein a

Antibodies for Western Blotting and Immunofluorescence

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

Mouse monoclonal antibodies were purchased from Invitrogen (CUL1-2H4C9: #32-2400), Sigma (FLAG-M2: #F3165, β-actin: #A-1978), Covance (HA-16612: #MMS-101P) and Santa Cruz (CD147 8D6: #sc-21746): Rabbit polyclonal antibodies were from Millipore (MCT1: #AB-3538P), Bethyl (DDB1: #A300-462A, CUL4A: #A300-739A), Sigma (FLAG, #F7425), Cell Signaling (α/β-tubulin: #2148, IKZF1: #5443, IKZF3: #12720), Proteintech (CUL4B: #12916-1-AP) and Santa Cruz (HA Y-11: #sc-805. A polyclonal antibody against CRBN was generated by immunizing rabbits with a mixture of two peptides containing amino acids 1-19 and 424-437 of human CRBN (MAGEDQQDAAHNMGNHLPC (SEQ. ID NO: 1) and CPTIDPTEDEISPDK (SEQ ID NO: 2), respectively). Secondary antibodies (anti-rabbit IgG, anti-mouse IgG or protein-A coupled with horseradish peroxidase) were from GE Healthcare. Secondary antibodies (anti-rabbit IgG and anti-mouse IgG) coupled to Alexa Fluor 594 or Alexa Fluor 488 for immunofluorescence and flow cytometry were from Life technologies.

US10987345B2. Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases (2021-04-27). Klinikum Rechts Der Isar Der Technischen Universitat Munchen [DE]. Inventors: Florian Bassermann [DE], Ruth Eichner [DE], Vanesa Fernandez-Saiz [DE].

+ Open protocol

+ Expand

Mouse Monoclonal Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

Mouse monoclonal antibodies were purchased from Invitrogen (CUL1-2H4C9: #32-2400), Sigma (FLAG-M2: #F3165, β-actin: #A-1978), Covance (HA-16B12: #MMS-101P) and Santa Cruz (CD147 8D6: #sc-21746). Rabbit polyclonal antibodies were from Millipore (MCT1: #AB-3538P), Bethyl (DDB1: #A300-462A, CUL4A: #A300-739A), Sigma (FLAG, #F7425), Cell Signaling (α/β-tubulin: #2148, IKZF1: #5443, IKZF3: #12720), Proteintech (CUL4B: #12916-1-AP) and Santa Cruz (HA Y-11: #sc-805. A polyclonal antibody against CRBN was generated by immunizing rabbits with a mixture of two peptides containing amino acids 1-19 and 424-437 of human CRBN (MAGEDQQDAAHNMGNHLPC (SEQ ID NO: 1) and CPTIDPTEDEISPDK (SEQ ID NO: 2), respectively). Secondary antibodies (anti-rabbit IgG, anti-mouse IgG or protein-A coupled with horseradish peroxidase) were from GE Healthcare. Secondary antibodies (anti-rabbit IgG and anti-mouse IgG) coupled to Alexa Fluor 594 or Alexa Fluor 488 for immunofluorescence and flow cytometry were from Life technologies.

US10398688B2. Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases (2019-09-03). Klinikum Rechts Der Isar Der TU München [DE]. Inventors: Florian Bassermann [DE], Ruth Eichner [DE], Vanesa Fernandez-Saiz [DE].

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!